期刊文献+

根治性前列腺切除手术Gleason评分升级和切缘阳性不良病理特征的影响因素

Influencing factors of the upgrading of Gleason score and adverse pathological features of positive incisal margin after radical prostatectomy
在线阅读 下载PDF
导出
摘要 根治性前列腺切除术是临床上治疗局限性前列腺癌的常用手段,手术病理是后续治疗的重要依据。但是手术病理会出现Gleason评分升级和切缘阳性等不良病理情况,这两种不良病理都与不良预后相关,尤其是术后出现生化复发。了解相关的高危因素有助于制定个性化治疗方案,规避术后不良病理发生,提高患者生存质量。该文综述了根治性前列腺切除手术Gleason评分升级和切缘阳性不良病理特征的影响因素。 Radical prostatectomy is a common clinical treatment for localized prostate cancer.Surgical pathology is an important basis for follow-up treatment.However,the surgical pathology can present with adverse pathologic features,including the upgrading of Gleason score and positive incisal margins,both of which are related to poor prognosis,especially postoperative biochemical recurrence.Understanding the relevant high-risk factors can help to provide optimal individualized treatment,avoid the occurrence of postoperative adverse pathology and improve the quality of life of patients.This paper reviews the influencing factor of the upgrading of Gleason score and adverse pathological features of positive incisal margin after radical prostatectomy.
作者 张国辉 李建昌 柳建军 罗帆 王帆 连湃 ZHANG Guo-hui;LI Jian-chang;LIU Jian-jun;LUO Fan;WANG Fan;LIAN Pai(Department of Urology,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524001,China)
出处 《广东医科大学学报》 2023年第2期220-226,共7页 Journal of Guangdong Medical University
关键词 前列腺肿瘤 根治性前列腺切除术 GLEASON评分 切缘阳性 prostatic neoplasms radical prostatectomy Gleason score positive incisal margins
  • 相关文献

参考文献10

二级参考文献68

  • 1常江平.前列腺增生体积和患者年龄对PSA的影响[J].临床泌尿外科杂志,1996,11(4):207-209. 被引量:10
  • 2Wilt T J, Brawer M K, Jones KM, Barry M J, Aronson W J, et al. Radical prostatectomy versus observation for localized prostate cancer. IV Engl J Med 2012; 367: 203-13.
  • 3BiU-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, etal. Radical prostatectomy versus watchful waiting in early prostate cancer. N EnglJ Med 2011; 364: 1708-17.
  • 4Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, et al. Outcomes of localized prostate cancer following conservative management. JAMA 2009; 302: 1202-9.
  • 5SchrOder FH, Hugosson J, Roobol M J, Tammela TL, Ciatto S, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012; 366: 981-90.
  • 6Coen J J, Feldman AS, Smith MR, Zietman AL. Watchful waiting for localized prostate cancer in the PSA era: what have been the triggers for intervention? BJU Int2011; 107: 1582-6.
  • 7Cooperberg MR, Vickers A J, Broering JM, Carroll PR. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer 2010; 116: 5226-34.
  • 8PIoussard G, Masson-Lecomte A, Beauval JB, Ouzzane A, Bonniol R, eta/. Radical prostateotomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification. Urology 2011; 78: 607-13.
  • 9Lawrentschuk N, Trottier G, Kuk C, Zlotta AR. Role of surgery in high-risk localized prostate cancer. Curr Onco12010; 17 Suppl 2: $25-32.
  • 10Connolly SS, Cathcart P J, Gilmore P, Kerger M, Crowe H, et al. Robotic radical prostatectomy as the initial step in multimodal therapy for men with high-risk Iocalised prostate cancer: initial experience of 160 men. BJU Int 2012; 109: 752-9.

共引文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部